Proposed issue of securities
Update Summary
For personal use only
Entity name
MEDIBIO LIMITED
Announcement Type
Update to previous announcement
Date of this announcement
20/1/2022
Reason for update to a previous announcement
The updated Appendix 3B notes that the Offer is now partially underwritten up to 1 million dollars, and provides a summary of the significant events that could lead to the partial underwriting agreement being terminated.
Refer to next page for full details of the announcement
Proposed issue of securities | 1 / 12 |
Proposed issue of securities
Part 1 - Entity and announcement details
For personal use only
1.1 Name of +Entity
MEDIBIO LIMITED
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.
If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).
1.2 | Registered Number Type | Registration Number |
ABN | 58008130336 | |
1.3 | ASX issuer code | |
MEB |
1.4 The announcement is
Update/amendment to previous announcement
1.4a Reason for update to a previous announcement
The updated Appendix 3B notes that the Offer is now partially underwritten up to 1 million dollars, and provides a summary of the significant events that could lead to the partial underwriting agreement being terminated.
1.4b Date of previous announcement to this update
14/1/2022
1.5 Date of this announcement
20/1/2022
1.6 The Proposed issue is:
A standard +pro rata issue (non-renounceable or renounceable)
A placement or other type of issue
1.6a The proposed standard +pro rata issue is: + Non-renounceable
Proposed issue of securities | 2 / 12 |
Proposed issue of securities
Part 3 - Details of proposed entitlement offer issue
only | ||||
Part 3A - Conditions | ||||
3A.1 Do any external approvals need to be obtained or other conditions satisfied before the entitlement offer can | ||||
proceed on an unconditional basis? | ||||
use | No | |||
Part 3B - Offer details | ||||
Class or classes of +securities that will participate in the proposed issue and class or classes of +securities | ||||
personal | proposed to be issued | |||
ASX +security code and description | ||||
MEB : ORDINARY FULLY PAID | ||||
Is the proposed security a 'New | Will the proposed issue of this | If the entity has quoted company | ||
class' (+securities in a class that is | +security include an offer of | options, do the terms entitle option | ||
not yet quoted or recorded by ASX) | attaching +securities? | holders to participate on exercise? | ||
or an 'Existing class' (additional | Yes | No | ||
securities in a class that is already | ||||
quoted or recorded by ASX)? | ||||
Existing class | ||||
D tails of +securities proposed to be issued | ||||
ASX +security code and description | ||||
MEB : ORDINARY FULLY PAID | ||||
For | ISIN Code (if Issuer is a foreign company and +securities are non CDIs) | |||
ISIN Code for the entitlement or right to participate in a non-renounceable | ||||
issue (if Issuer is foreign company and +securities are non CDIs)
Offer ratio (ratio to existing holdings at which the proposed +securities will be issued)
The quantity of additional +securities to be issued
For a given quantity of +securities held
1 | 3 |
Proposed issue of securities | 3 / 12 |
Proposed issue of securities
What will be done with fractional entitlements?
Maximum number of +securities proposed to be issued (subject to rounding)
only | Fractions rounded up to the next | 687,018,109 |
whole number | ||
Offer price details for retail security holders | ||
In what currency will the offer be | What is the offer price per +security | |
made? | for the retail offer? | |
AUD - Australian Dollar | AUD 0.00500 | |
use | Oversubscription & Scale back details | |
personal | Will individual +security holders be permitted to apply for more than their | |
entitlement (i.e. to over-subscribe)? | ||
Yes | ||
Describe the limits on over-subscription | ||
Eligible shareholders who apply for their Entitlement in full may apply for additional Shares under the Shortfall. If eligible | ||
shareholders subscribe for more Shares than are available under the Shortfall, the Company will apply a scale-back | ||
procedure to ensure a fair allocation of the shortfall. | ||
Will a scale back be applied if the offer is over-subscribed? | ||
Yes | ||
Describe the scale back arrangements | ||
In the event of a scale back, Eligible Shareholders' applications will be scaled back using a consistent percentage across | ||
all applications. | ||
Will these +securities rank equally in all respects from their issue date with | ||
the existing issued +securities in that class? | ||
For | Yes | |
Attaching +Security |
Is the proposed attaching security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional +securities in a class that is already quoted or recorded by ASX)?
Existing class
Attaching +Security - Existing class (additional +securities in a class that is already quoted or recorded by ASX)
Proposed issue of securities | 4 / 12 |
use only
Proposed issue of securities
Details of attaching +securities proposed to be issued
ASX +security code and description
MEBOC : OPTION EXPIRING 28-FEB-2024
ISIN Code (if Issuer is a foreign company and +securities are non CDIs)
ISIN Code for the entitlement or right to participate in a non-renounceable issue (if Issuer is foreign company and +securities are non CDIs)
Offer ratio (ratio of attaching securities at which the new +securities will be issued)
The quantity of attaching +securities to be issued | For a given quantity of the new +securities issued |
1 | 2 |
What will be done with fractional entitlements? | Maximum number of +securities proposed to be issued |
Fractions rounded up to the next whole number | (subject to rounding) |
343,509,055 | |
Offer price details for retail security holders |
personal
In what currency will the offer be made?
AUD - Australian Dollar
Oversubscription & Scale back details
Will individual +security holders be permitted to apply for more than their entitlement (i.e. to over-subscribe)?Yes
Describe the limits on over-subscription
What is the offer price per +security for the retail offer?
AUD 0.00000
For
Eligible shareholders who apply for their Entitlement in full may apply for additional Shares under the Shortfall. If eligible shareholders subscribe for more Shares than are available under the Shortfall, the Company will apply a scale-back procedure to ensure a fair allocation of the shortfall.
Will a scale back be applied if the offer is over-subscribed?
Yes
Describe the scale back arrangements
In the event of a scale back, Eligible Shareholders' applications will be scaled back using a consistent percentage across all applications.
Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that
Proposed issue of securities | 5 / 12 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Medibio Limited published this content on 20 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 January 2022 03:25:16 UTC.